H.R. 6155 · 116th Congress
To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.
- Stage
- In committee
- Sponsor
- Glenn Grothman
- Introduced
- 2020-03-09
- Latest action
- 2020-03-09 · Introduced in House
Subjects
Health
Licensing and registrations
Prescription drugs
Drug safety, medical device, and laboratory regulation